Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
American Journal of Medical Genetics. Part A
|
May 16, 2015
Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life
Pamela L Wolters, Katherine M Burns, Staci Martin, et al.
Nature Genetics
|
May 20, 2024
Comparative cofactor screens show the influence of transactivation domains and core promoters on the mechanisms of transcription
Charles C Bell, Jesse J Balic, Laure Talarmain, et al.
American Journal of Ophthalmology
|
March 5, 2013
Visual outcomes in children with neurofibromatosis type 1 and orbitotemporal plexiform neurofibromas
Robert A Avery, Eva Dombi, Kelly A Hutcheson, et al.
Pediatric Neurology
|
May 19, 2007
Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas
Dusica Babovic-Vuksanovic, Brigitte C Widemann, Eva Dombi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2006
Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas
Brigitte C Widemann, Wanda L Salzer, Robert J Arceci, et al.
Developmental Cell
|
February 17, 2024
SLAM-ITseq identifies that Nrf2 induces liver regeneration through the pentose phosphate pathway
Vicky W T Tan, Talhah M Salmi, Anthony P Karamalakis, et al.
Nature Protocols
|
April 10, 2021
Identifying high-confidence capture Hi-C interactions using CHiCANE
Erle M Holgersen, Andrea Gillespie, Olivia C Leavy, et al.
Neuro-Oncology
|
February 7, 2014
Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas
Brigitte C Widemann, Eva Dombi, Andrea Gillespie, et al.
Nature Cell Biology
|
January 12, 2023
Targeting Menin disrupts the KMT2A/B and polycomb balance to paradoxically activate bivalent genes
Christina E Sparbier, Andrea Gillespie, Juliana Gomez, et al.
The New England Journal of Medicine
|
December 29, 2016
Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas
Eva Dombi, Andrea Baldwin, Leigh J Marcus, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
American Journal of Medical Genetics. Part A
|
May 16, 2015
Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life
Pamela L Wolters, Katherine M Burns, Staci Martin, et al.
Nature Genetics
|
May 20, 2024
Comparative cofactor screens show the influence of transactivation domains and core promoters on the mechanisms of transcription
Charles C Bell, Jesse J Balic, Laure Talarmain, et al.
American Journal of Ophthalmology
|
March 5, 2013
Visual outcomes in children with neurofibromatosis type 1 and orbitotemporal plexiform neurofibromas
Robert A Avery, Eva Dombi, Kelly A Hutcheson, et al.
Pediatric Neurology
|
May 19, 2007
Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas
Dusica Babovic-Vuksanovic, Brigitte C Widemann, Eva Dombi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2006
Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas
Brigitte C Widemann, Wanda L Salzer, Robert J Arceci, et al.
Developmental Cell
|
February 17, 2024
SLAM-ITseq identifies that Nrf2 induces liver regeneration through the pentose phosphate pathway
Vicky W T Tan, Talhah M Salmi, Anthony P Karamalakis, et al.
Nature Protocols
|
April 10, 2021
Identifying high-confidence capture Hi-C interactions using CHiCANE
Erle M Holgersen, Andrea Gillespie, Olivia C Leavy, et al.
Neuro-Oncology
|
February 7, 2014
Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas
Brigitte C Widemann, Eva Dombi, Andrea Gillespie, et al.
Nature Cell Biology
|
January 12, 2023
Targeting Menin disrupts the KMT2A/B and polycomb balance to paradoxically activate bivalent genes
Christina E Sparbier, Andrea Gillespie, Juliana Gomez, et al.
The New England Journal of Medicine
|
December 29, 2016
Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas
Eva Dombi, Andrea Baldwin, Leigh J Marcus, et al.
Page
of 3